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ABSTRACT
Background: Gastrointestinal (GI) and hepatobiliary disorders are the most common complaints in patients 
with HIV/AIDS disease. These fundamental problems have not yet been addressed and remains a rewarding 
area for research. Data about the problems are scarce, especially in Indonesia. This study was aimed to identify 
gastrointestinal problems in HIV/AIDS patients who were hospitalized in Adam Malik Hospital, Medan.
Method: A descriptive study was conducted based on medical records data from non-ambulatory HIV/AIDS 
patients who had GI problems and who were hospitalized in Internal Medicine wards of Adam Malik Hospital, 
Medan from 2010-2012. Spearman rank test was used to evaluate the correlation between CD4 level and GI 
problems among 68 patients with CD4 data.
Results: We found 647 HIV/AIDS patients, i.e. 524 (80.9%) male and 123 (19.1%) female patients. 
Gastrointestinal problems were found in 315 (48.7%) patient among them. Oral candidiasis was the most 
common case found in 306 (97.1%), which was followed by chronic diarrhea 73 (23.2%), oral candidiasis 
with chronic diarrhea 64 (20.3%), dyspepsia 22 (6.9%), non-cirrhotic ascites 20 (6.3%), acute diarrhea 8 
(2.5%), hepatomegaly 8 (2.5%), dysphagia 6 (1.9%), chronic hepatitis C virus 6 (1.9%), chronic hepatitis B 
virus 4 (1.3%), GI bleeding 3 (0.9%), and acute hepatitis A virus 1 (0.3%). Unfortunately, we found that there 
was only 68 data of CD4. Results of statistical tests showed a significant correlation between CD4 level and 
gastrointestinal problems (p = 0.04).
Conclusion: Oral candidiasis is the most common gastrointestinal problems in HIV/AIDS patients hospitalized 
in Internal Medicine Wards of Adam Malik Hospital. 
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ABSTRAK
Latar belakang: Gangguan saluran cerna dan hepatobilier adalah keluhan yang paling sering dijumpai pada 
penderita HIV/AIDS. Permasalahan ini belum semua dapat tertangani dan tetap menjadi topik yang menarik untuk 
dilakukan penelitian. Di Indonesia data mengenai permasalahan ini masih terbatas. Tujuan penelitian ini adalah untuk 
melihat gambaran kelainan gastrointestinal yang terdapat pada penderita HIV/AIDS di Rumah Sakit (RS) Adam Malik.
Metode: Studi deskriptif berdasarkan data rekam medis pasien HIV/AIDS rawat inap yang memiliki masalah 
gastrointestinal di bangsal Penyakit Dalam RS Adam Malik Medan tahun 2010-2012. Tes Spearman rank 
digunakan untuk mengetahui hubungan antara nilai CD4 dan gangguan saluran cerna pada 68 pasien dengan 
data CD4.
Hasil: Terdata 647 pasien HIV/AIDS yang dirawat pada periode tersebut, terdiri dari 524 (80,9%) laki-laki 
dan 123 (19,1%) perempuan. Sebanyak 315 (48,7%) pasien mengalami masalah pada pencernaan. Kandidiasis 
oral merupakan penyakit yang paling sering 306 (97,1%), diikuti oleh diare kronis 73 (23,2%), kandidiasis 
oral dengan diare kronis 64 (20,3%), dispepsia 22 (6,9%), asites non sirosis 20 (6,3%), diare akut 8 (2,5%), 
hepatomegali 8 (2,5%), disfagia 6 (1,9%), virus hepatitis C kronis 6 (1,9%), virus hepatitis B kronis 4 (1,3%), 
perdarahan saluran cerna 3 (0,9%), dan virus hepatitis A akut 1 (0,3%). Namun hanya ada 68 pasien yang 
memiliki data CD4. Secara statistik terdapat hubungan yang bermakna antara nilai CD4 dengan masalah 
gastrointestinal (p = 0,04).
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Simpulan: Kandidiasis oral adalah masalah gastrointestinal yang paling sering ditemukan pada penderita 
HIV/AIDS di bangsal Penyakit Dalam RS Adam Malik.
Kata kunci: gastrointestinal, HIV/AIDS, kandidiasis oral, CD4
INTRODUCTION
Human immunodeficiency virus infection/acquired 
immunodeficiency syndrome (HIV/AIDS) is a disease 
of the human immune system caused by infection of 
human immunodeficiency virus (HIV). The problems 
found in patients are generally correlated with some 
symptoms. The clinical symptoms are usually followed 
by a stage of disease, including acute infection, clinical 
latency, asymptomatic HIV, or chronic HIV. Since 
the beginning of the epidemic, almost 70 millions 
people have been infected with the HIV and about 
35 million people have died of AIDS. Globally, 34.0 
millions (31.4–35.9 millions) people had been living 
with HIV by the end of 2011.1 Prevalence of HIV 
among adults aged 15 to 49 years in USA is 0.7%. 
A cumulative total of 712,477 HIV infections was 
reported to WHO/Europe and European Center for 
Disease Prevention and Control (ECDC) by the end 
of 2010 and reached over 1.5 million in 2011.2 There 
are an estimated 3.5 million people living with HIV 
in South-East Asia Region; of these 37% are female. 
Five countries account for majority of the burden, i.e. 
India, Indonesia, Myanmar, Nepal and Thailand.3 The 
last data from Ministry of Health Republic of Indonesia 
showed that the total number of HIV were 103,759 
patients by March 2013; among them 43,347 were 
AIDS, of whom 8,288 died.4
Gastrointestinal (GI) and hepatobiliary symptoms 
are the most common complaints found in patients 
with HIV/AIDS disease. The GI tract is a long tube 
with one entrance (the mouth) and one exit (the anus); 
problems can occur in any section on the way down.5 
Approximately 50% of the patients infected with HIV 
present with gastrointestinal abnormalities and all of 
them virtually  develop gastrointestinal complications 
during the course of the disease.6 Gastrointestinal 
symptoms such as nausea, vomiting or diarrhea may 
occur early in acute infection.7,8,9 The severity and the 
duration of GI symptoms are associated with a more 
rapid disease progression. If GI symptoms persists and 
did not subside with standard therapy, it may be the 
sign of a more serious problem.
These fundamental problems has not yet been 
addressed and remains  a rewarding area for research. 
Data about the problems are scarce, especially 
in Indonesia. This study was aimed to identify 
gastrointestinal problems in HIV/AIDS patients who 
were hospitalized in Adam Malik Hospital, Medan.  
METHOD
Between January 2010 and December 2012, a 
retrospective study was conducted at Internal Medicine 
wards of Adam Malik Hospital, Medan. This study was 
attempted to explore all GI problems in HIV/AIDS 
patients. Medical records of 647 HIV/AIDS patients 
were evaluated; however, only 68 patients had CD4 
data and 58 patients among them were identified with 
gastrointestinal problems and 10 other had no data 
about gastrointestinal problems. 
HIV/AIDS patients were diagnosed based on 
WHO clinical criteria and laboratory findings such as 
enzyme-linked immuno assay (ELISA) and rapid test.7 
Data was analyzed using SPSS 17. Spearman rank test 
was used to evaluate the correlation between CD4 level 
and GI problems among 68 patients with CD4 data.
RESULTS
We found 647 HIV/AIDS patients, i.e. 524 
(80.9%) male and 123 (19.1%) female patients. The 
gastrointestinal problems were found in 315 (48.7%) 
subjects among them. Oral candidiasis (OC) were 
found in 306 (97.1%) patients and it was the most 
common case, which was followed by chronic diarrhea 
(CD) in 73  (23.2%) patients and oral candidiasis with 
chronic diarrhea in 64 (20.3%) patients. Acute hepatitis 
A was the least problem that occurred, which was found 
only in 1 patient. Unfortunately, we found only 68 data 
of CD4 to analyze the association between CD4 level 
and GI problems among them (Figure 1).
The baseline characteristics of CD4 level and GI 
problems among 68 patients are shown in Table 1. Male 
(75%) patients were dominant and 25% were female 
patients. The youngest was 15 years old and the eldest 
was 57 years old. According to WHO classification of 
HIV/AIDS, eligible patients were in Stage III (76.5%) 
and Stage IV (23.5%). The most common GI problems 
were oral candidiasis (77.9%), chronic diarrhea 
(11.8%) and acute diarrhea (2.9%). 
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Figure 1. Gastroenterohepatology problems in 315 HIV/AIDS 
patients
cytomegalovirus (CMV) may delay or prevent the 
occurrence of gastrointestinal opportunistic infections. 
We found 48.7% GI problems in HIV/AIDS patients 
and these data were confirmed with Malenbranche and 
Gazzard reports.6,10
Gastrointestinal (GI) manifestations of HIV disease 
include diarrhea, dysphagia and odynophagia, nausea, 
vomiting, weight loss, abdominal pain, anorectal 
disease, jaundice and hepatomegaly, GI bleeding, 
interactions of HIV and hepatotropic viruses, and 
GI tumors (Kaposi’s sarcoma and non-Hodgkin’s 
lymphoma). Diarrhea is the most common GI 
symptom in patients with HIV. In outpatient studies, 
the prevalence of diarrhea ranged from 0.9 to 14%.11 
This study reported that oral candidiasis was the most 
common problem (77.9%); while diarrhea (acute and 
chronic) occurred only in 14.7% cases; however, it 
does not differ from Wilcox et al reports.11
GI problems in HIV disease are most strongly 
associated with low CD4 counts (lowest CD4 count 
> 200 cells/mm3).12,13,14 In our study there was a 
significant correlation between the proportion of HIV/
AIDS patients who had gastrointestinal problems and 
CD4 level (p = 0.04). This result was consistent with 
previous study.
CONCLUSION
GI disorders are common complaints in patients 
with HIV/AIDS disease and oral candidiasis is the 
most dominant case. This study reported a significant 
correlation between CD4 level and gastrointestinal 
problems.
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Table 1. The baseline characteristics of the patients with CD4 
data 
Variable n  = 68
Sex
Male
Female
Age (years)
CD4 counts (cell/mm3)
< 200
≥ 200
Stadium
III
IV
GI problems
Oral candidiasis
Chronic diarrhea
Acute diarrhea
51 (75%)
17 (25%)
15-57(32.37)
64 (94.1%)
4 (5.9%)
52 (76.5%)
16 (23.5%)
53 (77.9%)
  8 (11.8%)
  2 (2.9%)
GI: gastrointestinal
Table 2. The correlation of gastrointestinal problems and CD4 
value of the patients with Spearman rank test
Variable n r p
CD4 68 0.249 0.040GI problems
GI: gastrointestinal; r: correlation
The correlation test between CD4 level and 
gastrointestinal problems showed a very weak positive 
and patterned results, as an increased CD4 level would 
be followed by less gastrointestinal problems (r = 
0.249). Results of statistical tests found a significant 
correlation between CD4 level and gastrointestinal 
problems (p = 0.04).
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GI problems are frequently found in HIV/AIDS 
patients, especially in people with low immune 
function (CD4 counts < 200 cell/mm2). Before a 
combination of  antiretroviral therapy is initiated, 
the best estimates suggested that 50-93% of all 
patients with HIV disease had marked GI symptoms 
during the course of their illness.6,10 Recent clinical 
experience suggests that effective anti-HIV therapy and 
chemoprophylaxis for pneumocystis carinii pneumonia 
(PCP), mycobacterium avium complex (MAC), and 
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